论文部分内容阅读
目的观察米非司酮应用于腹腔镜子宫肌瘤剔除术前的临床疗效。方法 65例确诊为子宫肌瘤的患者随机分为两组,观察组33例,给予米非司酮口服,12.5 mg/次,1次/d,连续服用3个月,停药1个月内手术;对照组32例,术前常规纠正贫血后行腹腔镜手术。所有患者术前诊断性刮宫病理结果提示排除恶性病变。比较两组术前贫血情况、肌瘤直径大小、肝肾功能情况、以及手术所需时间、术中出血量等。结果观察组与对照组比较,观察组患者在用药期间均出现闭经,贫血改善明显,肌瘤最大直径均缩小,术中出血量明显减少,手术时间明显缩短,差异均具有统计学意义(P<0.05)。肝肾功能无明显改变。结论米非司酮应用于腹腔镜子宫肌瘤剔除术前可改善贫血,缩小肌瘤体积,缩短手术时间,减少术中出血量,对肝肾功能影响不明显。
Objective To observe the clinical effect of mifepristone applied before laparoscopic myomectomy. Methods 65 cases of uterine fibroids were randomly divided into two groups, the observation group of 33 cases, mifepristone given orally, 12.5 mg / time, 1 time / d, taking 3 consecutive months, withdrawal within 1 month Surgery; control group of 32 patients, preoperative routine correction of anemia after laparoscopic surgery. All patients with preoperative diagnostic curettage pathology prompted the removal of malignant lesions. Preoperative anemia was compared between two groups, fibroids size, liver and kidney function, as well as the time required for surgery, blood loss and so on. Results Compared with the control group, the patients in the observation group showed amenorrhea during the medication, the anemia was obviously improved, the maximum diameter of the fibroids was reduced, the amount of bleeding during operation and the time of operation were significantly shortened (P < 0.05). No significant change in liver and kidney function. Conclusion The application of mifepristone in the treatment of laparoscopic myomectomy can improve anemia, reduce the size of fibroids, shorten the operation time, reduce the amount of intraoperative bleeding, and have no obvious effect on the liver and kidney functions.